About NCC MEDICAL GROUP
NCC MEDICAL GROUP is an internationally recognized manufacturer specializing in neurodiagnostic and neuro-monitoring technologies. Since its establishment in 1997, NCC has focused on developing advanced solutions for EEG, EMG, PSG, and intraoperative neurophysiological monitoring systems. Through continuous innovation and global collaboration, the company has become a trusted partner for hospitals, research institutes, and medical distributors worldwide.
As a nationally recognized SRDI “Little Giant” enterprise, NCC represents a new generation of high-technology manufacturers in the medical device industry. The SRDI designation—standing for Specialized, Refined, Differential, and Innovational—is awarded by government authorities to companies that demonstrate strong technological capabilities and possess proprietary core innovations. This recognition reflects NCC’s long-term commitment to precision engineering and medical research.
The company’s global operational structure is designed to ensure both technological leadership and international regulatory compliance. NCC’s research and manufacturing center is located in Shanghai, China, where a multidisciplinary team of engineers and neuroscientists focuses on the development of cutting-edge neurophysiology equipment and medical consumables. This facility integrates advanced manufacturing technologies, strict quality management systems, and continuous R&D innovation.
Quality assurance and international regulatory coordination are managed through NCC’s Singapore operations hub. This global compliance center ensures that all NCC products meet the rigorous standards required for international medical device distribution. By aligning manufacturing quality with international regulatory frameworks, NCC guarantees that its neurodiagnostic solutions maintain consistent performance across global markets.
Over the past two decades, NCC has built a comprehensive portfolio covering IONM systems, EEG/PSG monitoring solutions, EMG diagnostic devices, and specialized medical consumables. Among these solutions, electrode technologies—such as the Electrodes Head systems used in neurophysiology diagnostics—play a crucial role in ensuring precise signal acquisition and reliable clinical outcomes.
NCC’s global impact continues to expand through an extensive distribution network and strong clinical partnerships. Today, the company’s technologies are used in more than 50 countries and over 5,000 hospitals across China. These installations range from leading university hospitals to regional medical centers and private diagnostic facilities.
To support healthcare providers worldwide, NCC has established 31 training and technical support centers across China. These centers provide comprehensive professional education programs for clinicians, biomedical engineers, and neurophysiology technicians. Through the NCC Innovation Academy, medical professionals gain access to continuous training in EEG, EMG, and intraoperative monitoring technologies.
In addition, the NeuGuard Service Platform provides hospitals and distributors with technical assistance, product updates, and system integration guidance. This service infrastructure ensures that NCC’s neurodiagnostic equipment and medical consumables—including advanced Electrodes Head solutions—can be implemented efficiently in clinical environments.
Looking forward, NCC continues to expand its global distributor network and strengthen partnerships with healthcare institutions worldwide. Guided by the mission of “Safeguarding Life and Health,” NCC remains committed to developing technologies that support safer surgeries, more precise neurological diagnostics, and improved patient outcomes.
Copyright © NCC Medical Co., Ltd. - Privacy policy